Norwegian university hospital offering clinical trial infrastructure, patient cohort access, and GDPR-compliant biomedical data for European research consortia.
St Olav's Hospital (St Olavs Hospital HF) is one of Norway's largest university hospitals, located in Trondheim and closely affiliated with NTNU (Norwegian University of Science and Technology). The hospital combines tertiary clinical care with substantial biomedical research activity, giving it a dual identity as both a healthcare provider and a research institution. In European projects, it has contributed as a clinical site and institutional data holder — offering access to patient cohorts, hospital-grade data infrastructure, and clinical research expertise. Its H2020 footprint is focused on research infrastructure: first in paediatric clinical trial networks, then in open life science data platforms under the European Open Science Cloud.
Participated as third party in PedCRIN (2017–2021), the Paediatric Clinical Research Infrastructure Network, indicating a role as a clinical site or data contributor for child health studies.
Contributed to EOSC-Life (2019–2023), an EU initiative building open digital infrastructure for biology, with keywords including EOSC, cloud, and biological medical research infrastructures.
GDPR appears explicitly in the EOSC-Life keyword set, suggesting St Olav brought hospital-level data protection expertise to the consortium's data-sharing framework.
In its earlier H2020 involvement (2017), St Olav's focus was narrowly clinical — contributing to a network specifically designed to enable paediatric clinical trials across Europe, where real hospital sites are the essential ingredient. By 2019, the focus shifted toward the broader challenge of open, cloud-based biological data infrastructure, reflecting growing European pressure to make research data FAIR and GDPR-compliant. This progression — from clinical site to data infrastructure contributor — suggests the hospital is building capacity in research data management alongside its traditional clinical research role.
St Olav's is moving from being a passive clinical contributor toward active participation in European data infrastructure, suggesting future interest in health data platforms, federated data spaces, and GDPR-compliant biomedical data sharing.
St Olav's has exclusively participated as a third party in both recorded H2020 projects — never as coordinator or named participant — which is typical of large hospitals that contribute clinical access, patient data, or institutional credibility rather than project management. This third-party role means they are recruited for what they hold (patients, data, accreditation) rather than what they manage. They appear in very large, multi-country consortia, consistent with their value as a prestigious Norwegian university hospital that lends legitimacy and real-world clinical grounding to infrastructure projects.
Despite only two projects, St Olav's is connected to 85 unique consortium partners across 20 countries — a sign that both projects were large pan-European infrastructure initiatives rather than small bilateral collaborations. Their network is broad and diverse, not concentrated around a specific national cluster.
St Olav's Hospital brings something most research organizations cannot: a live clinical environment with real patient populations, hospital-grade data systems, and the regulatory legitimacy of a national university hospital. For consortia that need a credible Nordic clinical site — especially in paediatrics or life science data — few Norwegian institutions match this combination of research tradition (NTNU affiliation) and clinical scale. Their explicit GDPR keyword presence also signals they can navigate sensitive health data sharing within European legal frameworks, which is a growing bottleneck in multi-country health research.
